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Summary
Objective: It was hypothesized that controlled, scaffold removal in engineered cartilage constructs would improve their collagen content and
mechanical properties over time in culture.
Design: Preliminary experiments characterized the effects of agarase on cell-free agarose disks and cartilage explants. Immature bovine
chondrocytes were encapsulated in agarose, cultured to day 42, and incubated with 100 units/mL agarase for 48 h. After treatment, constructs
were cultured to day 91. The compressive Young’s modulus and dynamic modulus of the constructs were determined every 2 weeks and
immediately after agarase treatment. Post-mechanical testing, constructs were processed for biochemistry and histology.
Results: Agarase treatment on explants had no detrimental effect on the cartilage matrix. Treatment applied to engineered constructs on day
42 did not affect DNA or collagen content. Agarase treatment decreased tissue GAG content (via GAG loss to the media) and Young’s mod-
ulus, both of which recovered to control values over time in culture. By day 91 agarase-treated constructs possessed w25% more DNA,
w60% more collagen, and w40% higher dynamic modulus compared to untreated controls.
Conclusions: Scaffold degradation increased construct collagen content and dynamic mechanical properties, afﬁrming the experimental
hypothesis. The mechanism may lie in increased nutrient transport, increased space for collagen ﬁbril formation, and cellular response to
the loss of GAG with agarase treatment. The results highlight the role of the scaffold in retaining synthesized matrix during early and late tissue
formation. This work also shows promise in developing an engineered tissue that may be completely free of scaffold material for clinical
implantation.
ª 2008 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
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Engineered articular cartilage cultured with a temporal
application of transforming growth factor b3 (TGF-b3) pos-
sesses a physiologic compressive Young’s modulus and
glycosaminoglycan content1. The application of dynamic
loading to these constructs further increases their mechan-
ical properties2, which may be due to loading-induced con-
vective transport3. However, the collagen content and
dynamic modulus of these engineered tissues, even with
applied loading, remain sub-physiologic. Given the relation-
ship between collagen and mechanical properties in carti-
lage4,5, improving the collagen network in engineered
cartilage may be necessary to develop a functional, clinical
replacement for damaged cartilage. This low collagen con-
tent is a pervasive problem in cartilage engineering,*Address correspondence and reprint requests to: Dr Clark T.
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220regardless of bioreactor conditions and scaffold material
(e.g.,6,7). The formation of a mechanically competent tissue
in vitro may be clinically relevant to prevent iatrogenic dam-
age peri-operatively, along with host cell inﬁltration and
ﬁbrocartilage formation in vivo.
In tissue engineering, scaffolds present a three-
dimensional environment to support cell phenotype,
increase diffusional surface area, and entrain synthesized
matrix products that form tissue8. Both degradable and
non-degradable scaffolds have been adopted for cartilage
tissue engineering (e.g.,9e11). Premature scaffold degrada-
tion canpermit escapeof cell products to the surroundingme-
dia before adequate tissue formation can occur. In contrast,
delayed scaffold degradation may result in insufﬁcient nutri-
ent transport and/or physical space that impede formation
of a fully competent tissue. Agarose has been used
extensively as a model scaffold for cartilage tissue engineer-
ing research10,12e15. The concentration of the gel dictates the
scaffold structure, mechanical properties, and transport
properties16e18 and this can be utilized to direct tissue devel-
opment in cartilage engineering19,20. As agarose is not de-
gradable by chondrocytes10, changes to the construct
properties can be directly attributed to chondrocyte anabolic
221Osteoarthritis and Cartilage Vol. 17, No. 2and catabolic activities. However, agarose can be enzymat-
ically degraded by the commercially available enzyme agar-
ase21e23 and the controlled degradation of the scaffold could
be used to beneﬁcially modulate engineered cartilage tissue
development in culture.
It is hypothesized that following an initial period of growth
where the scaffold provides suitable retention of matrix prod-
ucts, the degradation of the scaffold will improve the collagen
content and mechanical properties of engineered cartilage
over time in culture. In Study 1, agarose disks and articular
cartilage explants were exposed to agarase under culture
conditions (37C, 5% CO2) to assess the enzyme’s effects
on agarose, as well as any potential harmful effects on carti-
lage extracellular matrix (ECM). In Study 2, agarase was
added to engineered cartilage after matrix had developed
and a nutrient diffusion limitation would be present based on
previous experience with this model system24. A novel, aga-
rose assay was devised to quantify the amount of scaffold
degradation achieved with this enzymatic technique. Finally,
based on the results of the engineered cartilage study, Study
3wasdevised toevaluate the removal of glycosaminoglycans
on the efﬁcacy of the agarase enzyme. The results from these
studies aim to shed light on the possible beneﬁts of scaffold
degradation in the engineering of articular cartilage.MethodSTUDY 1: AGARASE CHARACTERIZATIONMolten agarose (2% weight/volume, Type VII, Sigma Aldrich, St. Louis,
MO) was cast between two glass plates and cooled at room temperature
for 20 min. Disks (B4.0 2.3 mm) were cored and either lyophilized and
weighed or incubated under sterile conditions with 0, 10, 50, and
100 units/mL agarase (Sigma) in phosphate buffered saline (PBS, Sigma)
(n¼ 4 per group). After this digestion period, agarose disks were washed,
lyophilized, and weighed to determine the amount of agarose digested.
Frozen, sterile, devitalized cartilage explants from bovine shoulder joints
were incubated with 50 units/mL agarase in PBS for 48 h at 37C and 5%
CO2 (n¼ 4 per group). After incubation, the explants were washed, digested
in proteinase K, and analyzed for biochemical content as described below to
assess matrix degradation due to agarase.STUDY 2: EFFECTS OF AGARASE ON ENGINEERED
CARTILAGE CONSTRUCTSCreation and culture of engineered constructs
Articular bovine chondrocytes were isolated from calf carpometacarpal
joints (n¼ 6) via an 11 h digestion of full thickness cartilage slices with
390 units/mL collagenase (Type V, Sigma) in 7.5 mL/g tissue of high-glucose
Dulbecco’s Modiﬁed Essential Medium (hgDMEM) supplemented with 5%
fetal bovine serum (FBS), amino acids, buffers, and antibiotics6. Cells
were resuspended and mixed with molten 4% type VII agarose (Sigma) in
PBS at 40C to yield a 2% agarose suspension with 30 106 chondro-
cytes/mL. This suspension was cast between two glass plates and cooled
for 20 min. Disks were cored (B4.0 2.3 mm) and cultured at 37C and
5% CO2 in 35 mL of chondrogenic media (hgDMEM, 1% ITSþ, 0.1 mM dexa-
methasone, 110 mg/mL sodium pyruvate, 50 mg/mL L-proline, 50 mg/mL
ascorbate-2-phosphate, sodium bicarbonate, and antibiotics1). Media was
changed bi-daily. For the ﬁrst 14 days, 10 ng/mL of TGF-b3 (R&D Systems,
Minneapolis, MN) was added with each media change1. Day 0 mechanical
testing was performed prior to TGF-b3 treatment. On day 42, half of the con-
structs were removed and cultured in chondrogenic media with 100 units/mL
agarase for 48 h. Constructs were then washed with media 3 and then
cultured in chondrogenic media for the rest of the study.
Mechanical testing
Constructs (n¼ 4e5 per group) were removed from culture on day 0, 14,
28, 42, 44 (immediately post-agarase treatment), 63, 77, and 91 for mechan-
ical testing. Testing was performed in unconﬁned compression as previously
described25. Constructs were placed in a custom testing device, equilibrated
under a creep tare load, then tested via a stress relaxation test (ramp veloc-
ity: 1 mm/s) to 10% strain (based on post-creep thickness). After equilibrium
was reached, a sinusoidal displacement of 40 mm amplitude was applied at1 Hz. Compressive Young’s modulus (EY) was determined from the equilib-
rium stress/strain response of the stress relaxation test. Dynamic modulus
(G*) at 1 Hz was calculated from the stress/strain response during the dy-
namic test. Following mechanical testing, samples were halved, with each
half either ﬁxed for histology or frozen at 80C for biochemistry.
Biochemical analysis
The samples were thawed, weighed wet, lyophilized, reweighed dry, and di-
gested for 16 h at 56C with 1 mg/mL proteinase K (EMD Biosciences, San
Diego CA) in 50 mM Tris buffered saline with ethylenediaminetetraacetic acid
(EDTA), iodoacetamide, and pepstatin A (Sigma Aldrich)26. Using these di-
gests, glycosaminoglycan (GAG) content was determined via the dimethyl-
methylene blue (DMMB) dye-binding assay27, DNA content via the PicoGreen
assay (Invitrogen,Carlsbad,CA), andcollagencontent via theorthohydroxypro-
line (OHP) colorimetric assay28. Collagen content was calculated by assuming
a 1:10 OHP-to-collagen mass ratio29. Assays were adapted for use in 96-well,
micro-titer plates. GAG and collagen content was normalized to the construct
wet weight (% ww). The type II collagen content of samples was determined
from the proteinase K digests via a custom enzyme-linked immunosorbent as-
say (ELISA) describedpreviously24,26. The type II collagen content wasnormal-
ized to the total collagen content of the disks as determined by the OHP assay.
Agarose quantification
A novel agarose quantiﬁcation assay was devised to measure the galac-
tose produced via enzymatic degradation of agarose with agarase (Sigma).
Proteinase K digests were vortexed and centrifuged at 100g for 30 s to sed-
iment undigested agarose while avoiding the pelleting of soluble matrix pro-
teins. The supernatant was removed and frozen for storage and the pellet
was washed and centrifuged 3 with PBS to remove any remaining matrix
proteins. These pellets were then liqueﬁed in PBS at 65C and cooled to
43C, at which 100 units/mL of agarase was added to each sample and in-
cubated overnight. Then the galactose content of these samples was deter-
mined via the Amplex Red kit (Invitrogen). Values obtained from control and
agarase-treated constructs were normalized to day 0 disks.
Histology
Samples were ﬁxed in acideethanoleformalin30 for 48 h at 4C, dehydrated,
cleared, embedded in TissuePrep embeddingmedia (Fisher Scientiﬁc, Pittsburgh,
PA), and sectioned at 6 mm. Sections were then stained in Safranin O, and Picro-
sirius Red to study cell proliferation/distribution, proteoglycans, and collagen.
Statistical analysis
Statistics were performed using the Statistica (Statsoft, Inc., Tulsa, OK)
software package. Groups were examined using multivariate analysis of var-
iance with EY, GAG, collagen, DNA, agarose, and type II collagen as the de-
pendent variables and culture time and agarase treatment as the
independent variables. Fisher’s least-signiﬁcant different (LSD) post hoc
tests were carried out with a¼ 0.05, n¼ 4e5 per group.STUDY 3: EFFECTS OF PROTEOGLYCAN REMOVAL ON
AGAROSE DIGESTIONDay 91 engineered constructs from Study 2 were incubated for 5 h at 37C
in either chondrogenic media (untreated control) or in sterile 2.0 M CaCl2 solu-
tion (treated)31e34 to extract proteoglycans (PGs). This CaCl2 technique was
previously found to extract>60%of total proteoglycans in engineered cartilage
tissue (not shown). After incubation, disks were washed 3 with media for
5 min under gentle agitation. Treated and untreated constructs were then incu-
bated with control media or 100 units/mL agarase as described above. This re-
sulted in four groups (n¼ 4 per group): control, agarase only, CaCl2-only, both
treatments (CaCl2eagarase). These constructs were analyzed for biochemical
and agarose content was evaluated as described above.
Constructs were prepared for imaging using scanning electron micros-
copy. Samples were halved and ﬁxed for 24 h at 4C in an electron micros-
copy (EM) ﬁxative (0.5% gluteraldehyde, 2% paraformaldehyde, 0.05 M
cacodylate buffer; pH 7.2). Then samples were washed in distilled water
and viewed in a FEI Quanta environmental scanning electron microscope
(ESEM) with beam strength of 10e15 kV at 500e1000 magniﬁcation.ResultsSTUDY 1: AGARASE CHARACTERIZATIONIncreased agarase concentration progressively increased
the degradation of the agarose hydrogel, with 100 units/mL
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Fig. 1. Results of Study 1 e Agarase characterization: Agarase enzyme was found to signiﬁcantly reduce the dry weights of cell-free agarose
disks, with increasing degradation found with increasing agarase concentration (A). The agarase enzyme was found to have no signiﬁcant
effects on the matrix composition of frozen cartilage explants (B).
222 K. W. Ng et al.: Scaffold removal for engineered cartilagefound to completely digest the agarose during the 48 h incu-
bation period [Fig. 1(A)]. Cartilage disks were found to be
unaffected by agarase treatment, with a slight but insigniﬁ-
cant decrease noted in GAG content [Fig. 1(B)]. Biochemi-
cal values obtained for cartilage [GAGw6.5% ww, collagen
w22% ww, Fig. 1(B)] agreed well with reported values in
literature35.STUDY 2: EFFECTS OF AGARASE ON TISSUE
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Fig. 2. Agarose quantiﬁcation of engineered cartilage in Study 2:
Agarose quantiﬁcation found that agarase treatment reduced aga-
rose content to 55 3% of control values. Agarose content was
unaffected with time in culture, conﬁrming previous ﬁndings by
Mauck et al10.Agarase treatment removed approximately w45% of the
agarose in the constructs, with 55 3% of the agarose
remaining (Fig. 2). Agarose content in both controls and in
agarase-treated tissues was found to be unaffected with
extended culture time, consistent with previous ﬁndings10.
Control construct EY and G* increased over time to
w600 kPa and w2.75 MPa, respectively, but plateaued
after day 63 (Fig. 3). GAG content and collagen content nor-
malized to wet weight reached values of w6.5% ww and
w2.5% ww, with no signiﬁcant increases in GAG after
day 63 and no signiﬁcant increases in collagen after day
42 (Fig. 4). Dry weight increased from 2.4 1.0 to
9.6 2.9 mg after 91 days in culture. DNA content was
initially 4154 57 ng/construct and increased w2 by
day 28 (8643 178 ng/construct, P< 0.05), with no signiﬁ-
cant changes observed after day 28.
Agarase treatment did not result in construct disintegra-
tion, as constructs appeared to maintain their shape and
could be easily manipulated. A signiﬁcant decrease in EY
and G* was observed immediately post-treatment on day
44, with additional decreases observed on day 63 (Fig. 3).
A similar trend was observed in GAG content [Fig. 4(A)],
with GAG release to media measured at a rate of
w320 mg/construct/day during the 2 days incubation. Imme-
diately after this incubation period, this rate diminished to
w130 mg/construct/day and returned to control levels of
w45 mg/construct/day after day 63. After agarase treatment
on day 44, constructs were signiﬁcantly smaller than control
tissue (Fig. 5, P< 0.05) and possessed signiﬁcantly lower
dry weights vs. controls (4.9 0.3 vs 7.3 1.2 mg,P< 0.05). After 91 days in culture, agarase-treated tissue
dry weights recovered to 7.7 1.5 mg, with no signiﬁcant
differences in size or weight to control constructs at this
time point. No DNA or collagen release to media was
detected after agarase treatment. However, DNA content
signiﬁcantly increased by an additionalw25% with agarase
treatment from day 44 to 77 and plateaued by day 91 (day
91 value: 10,584 231 ng/construct, P< 0.05 vs control).
Both GAG [Fig. 4(A)] and EY [Fig. 3(A)] of treated constructs
recovered to control values (P¼ 0.9) by day 91 and G*
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Fig. 3. Young’s modulus and dynamic modulus (G* 1 Hz) of control and agarase-treated constructs in Study 2. Control constructs (white) in-
creased in compressive Young’s modulus (A) and compressive dynamic modulus measured at 1 Hz (G* 1 Hz, B) over time in culture. After
addition of agarase on day 42, tissue mechanical properties initially decreased post-agarase treatment when measured on day 44, but recov-
ered to control levels after additional culture time (A, black bars). The G* 1 Hz of agarase-treated tissue recovered to control levels on day 77
and surpassed control tissues by day 91 (B, black bars). *P< 0.05 vs d0, **P< 0.05 vs d14, ***P< 0.05 vs d28, 6P< 0.05 vs d42, yP< 0.05
vs respective control, zP< 0.05 vs previous time point within same group.
223Osteoarthritis and Cartilage Vol. 17, No. 2[Fig. 3(B)] was signiﬁcantly greater than that of control
(3.94 0.20 vs 2.77 0.12 MPa, P< 0.05). Collagen con-
tent normalized to wet weight [Fig. 4(B)] did not signiﬁcantly
increase after agarase treatment (day 44), but did signiﬁ-
cantly increase compared to controls on days 77
(3.46 0.14 vs 2.44 0.14% ww, P< 0.05) and 91
(3.90 0.72 vs 2.45 0.18% ww, P< 0.05). Collagen con-
tent normalized to dry weight signiﬁcantly increased after
agarase treatment compared to controls (day 44:
20.78 3.76 vs 13.17 3.27% dw, P< 0.05), which is par-
tially due to GAG and agarose loss decreasing the overall
mass of agarase-treated constructs. However, the signiﬁ-
cant difference in collagen/dry weight between agarase
and control groups continued through the entire study
(day 91: 26.70 3.69 vs 16.60 2.82% dw, P< 0.05). Col-
lagen content normalized to DNA (ng/ng) showed slight, but
signiﬁcant increases between agarase and control groups
only on day 77 (74.01 3.63 vs 62.39 4.77, P< 0.05)
and day 91 (75.13 4.06 vs 64.84 1.92, P< 0.05).
Type II collagen, as determined via ELISA, represented
w68% of the total collagen and did not change with time
in culture or with agarase treatment.0%
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Fig. 4. GAG content and collagen content of control and agarase-treated
control tissues (white bars) increased early in culture, but reached a pla
lower GAG content immediately after treatment (day 44) that continued
was not affected by agarase treatment and continued to increase with
*P< 0.05 vs d0, **P< 0.05 vs d14, ***P< 0.05 vs d28, 6P< 0.05 vs d42
within sameHistology of agarase-treated samples on day 44 (Fig. 6)
found qualitative GAG loss throughout the constructs, con-
sistent with the quantitative results. The greatest GAG loss,
indicated by the absence of the Safranin O dye, was at the
periphery of constructs. Picrosirius Red showed a qualitative
increase in the collagen content of agarase-treated
samples.STUDY 3: EFFECTS OF PG REMOVAL ON
AGAROSE DIGESTIONCaCl2 extraction signiﬁcantly removedw80% of the total
proteoglycans as measured by the DMMB assay (control:
1126 168 mg GAG/construct vs CaCl2 treated:
195 14 mg GAG/construct, P< 0.05). Agarase treatment
alone was also found to comparably reduce GAG content
(agarase only: 147 38 mg GAG/construct, P< 0.05 vs
control). Both treatments (CaCl2eagarase) resulted in
a >95% reduction in GAG, with these constructs possess-
ing only 27 4 mg GAG/construct (P< 0.05 vs all groups).
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until day 63 before recovering to control values. Collagen content
time in culture, surpassing control values on day 77 and day 91.
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Fig. 5. Day 44 gross morphology of control and agarase-treated
constructs from Study 2. Immediately after agarase treatment,
treated constructs possessed smaller diameters and thicknesses
than untreated controls. This trend continued through time in
culture.
224 K. W. Ng et al.: Scaffold removal for engineered cartilagewas found to be unaffected by CaCl2 extraction (93 14%
and 95 11% of control values, respectively). Agarase
treatment signiﬁcantly reduced the measured agarose con-
tent, but did not fully remove the agarose scaffold, consis-
tent with results for Study 2 (58 7% agarose remaining,
P< 0.05 vs control). Combined CaCl2 and agarase treat-
ment further lowered agarose content below control and
agarase alone values (27 12%, P< 0.05 vs all groups).
All samples contracted under ESEM viewing due to the
eventual drying of the samples. The control tissue exhibited
relatively smooth surfaces with small bumps that may be
the embedded chondrocytes [Fig. 7(A)]. Proteoglycan
extraction led to the formation of large holes in the con-
struct, with ﬁbers appearing to span these holes
[Fig. 7(B)]. Agarase treatment led to much larger contraction
of construct with drying while viewed under ESEM and pos-
sessed a bumpy texture [Fig. 7(C)]. Combined treatments
revealed a contracted specimen with a more ﬁbrous
appearance compared to agarase alone and/or control
samples [Fig. 7(D)].Fig. 6. Safranin O and Picrosirius Red histology for Study 2 constructs.
construct, as indicated by decreased staining by Safranin O (left) com
Collagen appeared to increase in density, as indicated by the increases
well with the quantitativDiscussion
The primary purpose for agarose scaffold removal was to
increase the engineered cartilage collagen content and
mechanical properties. Constructs were cultured for 42
days and possessed a physiologic Young’s modulus (EY)
andGAGcontent prior to agarase treatment at this time point.
After 91 days in culture (49 additional days post-agarase
treatment), agarase treatment led to aw60% increase in col-
lagen content and a w40% increase in the dynamic modu-
lus, afﬁrming the proposed hypothesis. The rationale for
this approach was chosen so that the engineered tissue
could ﬁrst utilize the agarose scaffold for retaining matrix
products and then rely on the de novo matrix for structural
support upon digestion of the agarose scaffold. Agarase
scaffold degradation did not lead to construct disintegration,
cell loss, or collagen loss, validating this approach. Though
agarose was utilized for its known beneﬁts in maintaining
chondrocyte phenotype, the encouraging results from the
current studies are relevant to other scaffolds where degra-
dation can also be controlled (e.g., alginate11 and polyethyl-
ene glycol [PEG] hydrogels36).
From the results, the compressive properties of the aga-
rose scaffold, which do not degrade or change over time10,
can contribute only minutely to the overall mechanical prop-
erties of the engineered cartilage tissue after physiologic
matrix formation [i.e., w10 kPa vs w600 kPa, Fig. 3(A)].
Therefore, the changes in the construct mechanical proper-
ties with agarase treatment represent an interplay between
the functional role of GAG and collagen and the tissue’s
hydraulic permeability. Agarase treatment led to GAG loss
that led to a lower compressive EY, as expected based on
the functional mechanical role of GAG molecules37. The
values for both retained GAG and EY, however, were still
signiﬁcantly greater than day 0 values; this retention may
be attributed to the entrapment of the larger proteoglycans
in the remaining agarose and newly synthesized collagen
matrix, as well as potential binding of proteoglycan mole-
cules to the collagen matrix. Based on theoretical models
of cartilage matrix38e40, this decrease in GAG content
should result in a concomitant increase in hydraulic perme-
ability due to changes in steric and electrochemical interac-
tions. This change in the permeability is supported by theAgarase treatment was found to lead to GAG loss throughout the
pared to control tissues, especially at the construct periphery.
in Picrosirius Red staining (right). These results appear to correlate
e data in Fig. 4.
Fig. 7. ESEM images for Study 3 constructs. Under environmental scanning electron microscopy (ESEM), all constructs exhibited tissue con-
traction due to water evaporation over time during scanning. Untreated control tissues exhibited relatively smooth surfaces with small bumps
(arrows) that may be chondrocytes (A). Proteoglycan extraction via CaCl2 led to the formation of large holes with ﬁbers spanning the holes (B).
Constructs after agarase treatment exhibited greater contraction with drying during ESEM viewing and possessed a very bumpy texture (C).
Combined treatments revealed a contracted specimen with a more ﬁbrous appearance compared to agarase alone and/or control samples
(D). Magniﬁcation¼ 1000, scale bar¼ 100 mm.
225Osteoarthritis and Cartilage Vol. 17, No. 2histological ﬁndings and would improve nutrient/waste
transport, partially explaining the increases in matrix syn-
thesis following agarase treatment41,42. An increase in
hydraulic permeability would explain the decrease in
dynamic modulus post-agarase treatment as the dynamic
compressive properties of hydrated cartilage matrix depend
on tensile stiffness (imparted by collagen) and interstitial
ﬂuid pressurization, which is inversely related to permeabil-
ity43,44. With GAG content and permeability restored to con-
trol levels with time in culture, the higher dynamic modulus
of agarase-treated constructs over controls is likely due to
the increased collagen content, based on its known func-
tional role4,5. To validate these proposed mechanisms,
further experiments are needed to directly measure the per-
meability of engineered constructs pre/post-agarase treat-
ment along with the effects of GAG loss without agarose
loss (e.g., via chondroitinase-ABC).
The removal of the scaffold did not result in any apparent
loss of the de novo collagen matrix or construct disintegra-
tion, indicating the presence of an interconnected collagen
meshwork by 42 days. With the removal of the agarose
scaffold, the tissue engineered construct would be mostly
supported by its collagen matrix. The slight but signiﬁcantcontraction of the construct, noted by the decrease in size
and the apparent increase of collagen density observed
with histology, is likely due to the reduction in osmotic swell-
ing pressure from the loss of GAG molecules45e47 and not
to a collapse of the matrix structure. Indeed, agarase led to
improved matrix accumulation and tissue properties that
reﬂect favorable changes in chondrocyte microenvironment
post-treatment. Osmotic swelling pressure generated by
proteoglycans appears to be one of the major mechanisms
behind the size increase of chondrocyte-laden agarose con-
structs over time in culture and the stresses generated can
eventually lead to construct cracking48. After agarase treat-
ment, the GAG molecules that remain in the construct are
likely those that have bonded with the collagen meshwork
of the tissue; thus it is possible that the post-agarase syn-
thesized GAG molecules that are retained are likely to be
better aggregated and integrated with the collagen network
than those in the control tissue. The mechanism of proteo-
glycanecollagen interaction may be related to other carti-
lage proteins such as COMP49 and this is worth future
veriﬁcation.
The increased collagen content in engineered cartilage
after agarase treatment can be explained by the
226 K. W. Ng et al.: Scaffold removal for engineered cartilagecombination of increased chondrocyte number and in-
creased collagen accumulation per cell. The mechanisms
behind these changes are likely a combination of physical
and biological factors: The removal of the agarose scaffold
and unbound GAG molecules may have lead to increased
permeability (see above) and thereby improve nutrient/
waste transport allowing for increased matrix synthesis. In
addition, the loss of the agarose scaffold in the construct
would increase the space in which newly synthesized ma-
trix could occupy. The mechanism behind the cell prolifera-
tion observed from day 0 to 28 is likely due to the
collagenase digestion protocol, which has been found to
elicit transient proliferation in explant culture50. After agar-
ase treatment, the disruption of the extracellular matrix
and chondrocyte environment by the loss of scaffold and
GAG molecules may have triggered the second stage of
chondrocyte proliferation, consistent with ﬁndings in ex-
plants50,51. As matrix content was restored, this transient
cell proliferation was observed to cease. The use of type
II collagen ELISA conﬁrmed that the chondrocytes ap-
peared to possess their proper phenotype as evidenced
by a physiological type II collagen fraction. The increase
in collagen synthesis may be triggered by the GAG loss oc-
curring with agarase treatment. In explant cultures, Asan-
baeva et al. have found that chondroitinase-ABC
treatment of cartilage explants improved the collagen con-
tent, GAG synthesis (via sulfate incorporation), and tensile
mechanical properties over time in culture52. They pro-
posed that these changes were possibly due to chondro-
cyte response to changes in collagen pre-stress and/or
organization with enzyme treatment, but the exact mecha-
nisms remain unclear. Recent work on chondrocyte-seeded
agarose constructs53 and scaffold-free constructs54 has
found similar changes with GAG depletion.
A novel quantiﬁcation technique was devised to deter-
mine the agarose content in the constructs post-agarase
treatment. The difﬁculty arose from the lack of existing
methodologies to quantify agarose along with the need to
separate the agarose from the matrix proteins after protein-
ase K digestion. It was observed that the enzymatic diges-
tion to isolate matrix molecules did not appear to have any
effect on the agarose scaffold consistent with the known
effects of proteinase K to digest proteins (product literature,
EMD Biosciences). Therefore, the undigested matter was
pelleted, digested with agarase, and then the resulting
galactose released was determined as a means to measure
the agarose content. This agarose characterization of engi-
neered cartilage constructs treated with agarase found an
incomplete digestion that was unlike the complete digestion
found with cell-free disks. As the penetration of agarase in
to the construct relies on diffusion, there is likely a greater
effect of agarase on the construct periphery. Incomplete
penetration of the enzyme may not have greatly affected
the tissue properties as the peripheral region exhibits the
greatest matrix development24 and would be the region
most limiting to nutrient diffusion. In addition, as GAG mol-
ecules have been shown to impair tissue integration55, the
removal of agarose and GAG molecules at the construct
edges may improve construct integration with surrounding
host tissue.
The proteoglycan extraction via calcium chloride further
decreased the agarose content with agarase digestion.
However, though the agarose digestion was improved
with proteoglycan extraction, the exact mechanism behind
the decreased efﬁcacy of agarase remains unclear. One
possibility is that the galactose bonds present in GAG mol-
ecules56e58 may interfere with the action of agarase. Theefﬁcacy may also be tied in with permeability, restricting dif-
fusion of the enzyme to the inside of the engineered tissues.
This mechanism is possible as the calcium chloride extrac-
tion appeared to increase the pores in the tissue (Fig. 7)
and improve the agarose digestion. This indicates that com-
plete removal of the agarose may require additional enzy-
matic treatments to remove GAG molecules. Future
experiments need to determine the exact reason behind
the observed diminishment of the agarase enzyme
efﬁciency on the agarose in the engineered cartilage con-
structs. Another issue to be addressed with future research
is the batch-to-batch variations that may arise in the produc-
tion of the agarase enzyme.
The results of this study highlight the importance of con-
trolled scaffold degradation in the formation of engineered
cartilage. Controlled degradation of the agarose scaffold
employed in the current studies was achieved via the
enzyme agarase. Agarase treatment was found to remove
scaffold material and GAG molecules from the engineered
construct with no detrimental effects on chondrogenic activ-
ity. In addition, agarase-treated constructs possessed in-
creased collagen content and dynamic mechanical
properties relative to control over time in culture. This dem-
onstrates an important beneﬁt of controlled scaffold degra-
dation in cartilage tissue engineering, and may be
explained by increased nutrient transport, increased space
for collagen ﬁbril development, and stimulatory effects of
GAG loss. Future work will investigate the feasibility of com-
bining established bioreactor culture with scaffolds (e.g.,
applied dynamic loading10, prescribed mechanical inhomo-
geneity20) along with degradation to improve tissue proper-
ties and reduce scaffold content prior to clinical
implantation. Such an engineered tissue would combine
the advantages of current scaffold and scaffold-free
approaches and be free of possible biocompatibility issues
that may arise with host blood/tissue interactions.
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